Continuous glucose monitoring is helping diabetics and others do a better job of tracking their blood sugar and taking ...

This study highlights the successful development of a non-invasive biosensor for glucose monitoring, addressing many ...

Sequel Med Tech and Senseonics today announced a commercial development agreement to combine insulin delivery and glucose ...

Global sensation Nick Jonas has always been open about his health journey, and recently, the singer reflected on being ...

Abbott has signed an agreement with Epic to integrate data from its Libre continuous glucose monitoring systems directly into the EHR vendor’s platforms. The integration will allow healthcare ...

The partnership extends the compatibility of Sequel’s Twiist system to allow people with Type 1 diabetes to pair the device ...

may vary based on the continuous glucose monitoring (CGM) system used, resulting in differences that may affect the timing and choice of treatment decisions, such as insulin delivery or ...

The Eversense 365 is the first one-year continuous glucose monitoring system, offering convenience and accurate monitoring for diabetes patients. Disclaimer: This is an AI-generated summary of a ...

Future Market Insights (FMI) has revealed an insightful new report showcasing the remarkable growth trajectory of the global patient monitoring devices market. Valued at USD 46.4 million in 2022, the ...

Abbott (NYSE: ABT), the global leader in continuous glucose monitoring (CGM) biowearable technology1, today announced that it has entered a first-of-its-kind agreement to integrate data from its world ...

Discover how Samsung Galaxy Watch 8 non-invasive glucose monitoring is revolutionizing diabetes care and wearable health ...